| Old Articles: <Older 41771-41780 Newer> |
|---|
 |
The Motley Fool
June 21, 2010
Jordan DiPietro |
Covidien Management Staying Busy The medical device company is on an acquisition spree as of late.   |
The Motley Fool
June 21, 2010
Andrew Bond |
Mind the Gap Up How to play the large market gaps when China's yuan moves. |
The Motley Fool
June 21, 2010
Brian Richards |
How Toyota Can Get Back on Track A new ad campaign is exactly what Toyota needs. |
The Motley Fool
June 21, 2010
Rex Moore |
What China's Currency Change Means For Investors Investors cheer as China unpegs its currency. |
The Motley Fool
June 21, 2010
Erin Kutz |
Curis Misses Mark in Drug Trial; Genzyme Elects Board; GTC Cuts Jobs; and More Boston-Area Life Sciences News These drug and biomedical companies made news last week. |
The Motley Fool
June 21, 2010
Jordan DiPietro |
Foreign Stocks You Can Actually Buy: Greece Finding foreign stocks on U.S. indices can be difficult, so here's a start. |
The Motley Fool
June 21, 2010
Dave Mock |
A Big Upgrade for Clorox This bullish call comes from more than just one analyst. |
The Motley Fool
June 21, 2010 |
This Is Microsoft's Opportunity Microsoft's Xbox 360 had great strategic direction from the start. |
The Motley Fool
June 21, 2010
Rick Aristotle Munarriz |
Price War for Apple and Amazon? Barnes & Noble slashes the price of its e-book reader. |
The Motley Fool
June 21, 2010
Luke Timmerman |
Stanford Biodesign, a Hothouse for Medical Devices, Shares its Secret Sauce for Invention How do you measure an innovation's worth? By the real patients it helps. |
| <Older 41771-41780 Newer> Return to current articles. |
